Cite
Liang HW, Kao HL, Lin YH, et al. Everolimus-Eluting Bioresorbable Vascular Scaffold in Real World Practice - A Single Center Experience. Acta Cardiol Sin. 2017;33(3):250-257doi: 10.6515/acs20160901a.
Liang, H. W., Kao, H. L., Lin, Y. H., Hwang, J. J., Lin, M. S., Chiang, F. T., Lee, C. M., Yeh, C. F., Wang, T. D., Wu, C. K., Lin, L. Y., Tsai, C. T., & Chen, Y. H. (2017). Everolimus-Eluting Bioresorbable Vascular Scaffold in Real World Practice - A Single Center Experience. Acta Cardiologica Sinica, 33(3), 250-257. https://doi.org/10.6515/acs20160901a
Liang, Huai-Wen, et al. "Everolimus-Eluting Bioresorbable Vascular Scaffold in Real World Practice - A Single Center Experience." Acta Cardiologica Sinica vol. 33,3 (2017): 250-257. doi: https://doi.org/10.6515/acs20160901a
Liang HW, Kao HL, Lin YH, Hwang JJ, Lin MS, Chiang FT, Lee CM, Yeh CF, Wang TD, Wu CK, Lin LY, Tsai CT, Chen YH. Everolimus-Eluting Bioresorbable Vascular Scaffold in Real World Practice - A Single Center Experience. Acta Cardiol Sin. 2017 May;33(3):250-257. doi: 10.6515/acs20160901a. PMID: 28559655; PMCID: PMC5445242.
Copy
Download .nbib